<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.101008</article-id><article-id pub-id-type="publisher-id">ACM-33945</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20200100000_28328798.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  精神神经社会心理等因素在BMS发病机制中的相关进展
  Recent Advances of Biological Nerve and Social Psychology in the Pathogenesis of BMS
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>谢</surname><given-names>尚丰</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>何</surname><given-names>虹</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>雪婷</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>馨月</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>汪</surname><given-names>颖</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>浙江大学医学院附属口腔医院，浙江 杭州</addr-line></aff><aff id="aff3"><addr-line>浙江大学医学院附属口腔医院，浙江 杭州；浙江大学口腔医学院，浙江省口腔生物医学研究重点实验室，浙江 杭州</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>01</month><year>2020</year></pub-date><volume>10</volume><issue>01</issue><fpage>42</fpage><lpage>50</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    发病率增高、临床部位和症状多样、发病机理不明确、尤其治疗效果不确定，这一类以口腔各种不适为主诉的灼口综合征，不具有口腔相应组织器官的临床病损体征和组织细胞病理学变化的支持。生物神经、社会心理等因素在其发病机制中越来越有所体现，结合临床见解本文对其相关进展作一综述。
    Characterized by discomfort in the mouth, with no specific lesions or inflammatory signs, and an increasing incidence, diverse lesion sites and symptoms, unclear pathogenesis and uncertain treatment methods, the biological nerve and social psychological factors have increasingly emerged in the pathogenesis of the burning mouth syndrome. This review provides a summary of its current progress. 
  
 
</p></abstract><kwd-group><kwd>灼口综合征，舌痛，病因，生物神经，社会心理, Burning Mouth Syndrome</kwd><kwd> Glossodynia</kwd><kwd> Etiology</kwd><kwd> Biological Nerve</kwd><kwd> Social Psychology</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>精神神经社会心理等因素在BMS发病 机制中的相关进展<sup> </sup></title><p>谢尚丰<sup>1</sup>，何 虹<sup>1,2*</sup>，王雪婷<sup>1</sup>，张馨月<sup>1</sup>，汪 颖<sup>1</sup></p><p><sup>1</sup>浙江大学医学院附属口腔医院，浙江 杭州</p><p><sup>2</sup>浙江大学口腔医学院，浙江省口腔生物医学研究重点实验室，浙江 杭州</p><disp-formula id="hanspub.33945-formula47"><graphic xlink:href="//html.hanspub.org/file/8-1571130x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2019年12月25日；录用日期：2020年1月7日；发布日期：2020年1月14日</p><disp-formula id="hanspub.33945-formula48"><graphic xlink:href="//html.hanspub.org/file/8-1571130x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>发病率增高、临床部位和症状多样、发病机理不明确、尤其治疗效果不确定，这一类以口腔各种不适为主诉的灼口综合征，不具有口腔相应组织器官的临床病损体征和组织细胞病理学变化的支持。生物神经、社会心理等因素在其发病机制中越来越有所体现，结合临床见解本文对其相关进展作一综述。</p><p>关键词 :灼口综合征，舌痛，病因，生物神经，社会心理</p><disp-formula id="hanspub.33945-formula49"><graphic xlink:href="//html.hanspub.org/file/8-1571130x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/8-1571130x8_hanspub.png" /> <img src="//html.hanspub.org/file/8-1571130x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>随着人类生活的变化，生物神经与社会心理因素在灼口综合征(burning mouth syndrome，BMS)有所突现 [<xref ref-type="bibr" rid="hanspub.33945-ref1">1</xref>]。甚至与潜在性精神因素是否互为因果循环的关系，亦无明确。临床专业亟待规范的用药或有效的治疗措施等临床路径。兹作一定的梳理认识。</p></sec><sec id="s4"><title>2. BMS的主要发病情况</title><sec id="s4_1"><title>2.1. 患病率</title><p>文献报道的BMS患病率多有不同，一般人群中的BMS患病率为1.0%~3.7% [<xref ref-type="bibr" rid="hanspub.33945-ref2">2</xref>]。女性患病率高于男性，性别比可达到5:1~7:1 [<xref ref-type="bibr" rid="hanspub.33945-ref3">3</xref>]。患者的平均年龄是55~60岁，随着年龄增加患病率也随之升高，BMS在20岁以下人群中较少见到，目前尚罕见儿童和青少年BMS的报道 [<xref ref-type="bibr" rid="hanspub.33945-ref4">4</xref>]，与作者团队临床人群的年龄分布相吻合。但是当今社会的临床中，男女性发病率增长均居高不下；30岁以下的患者也在涌现。</p></sec><sec id="s4_2"><title>2.2. 发病率</title><p>Kohorst等 [<xref ref-type="bibr" rid="hanspub.33945-ref5">5</xref>] 基于人群的研究发现BMS的发病率为11.4/10万，或0.7%~15% [<xref ref-type="bibr" rid="hanspub.33945-ref3">3</xref>]，女性发病率高于男性，性别比为6:1。50~89岁的绝经后女性发病率最高，其中70~79岁的发病率达70.3/10万。50岁以后，不同年龄组的男性和女性BMS发病率均显著增加。</p><p>作者团队的临床数据初步显示男女比大致在1:4。但是不认为就诊性别分布的差异对BMS的诊疗和发病机理有明显意义。而是与文献 [<xref ref-type="bibr" rid="hanspub.33945-ref6">6</xref>] 支持相吻合，发现只有少部分患者的相关诱发事件尚为隐匿，初步发现大部分存在健康相关事件、人员环境或个人事件。</p></sec></sec><sec id="s5"><title>3. BMS的主要发病表现</title><p>BMS患者的临床表现可以是单一疼痛症状或混合症状，如伴发口干、味觉障碍麻、糙、木等感觉异常 [<xref ref-type="bibr" rid="hanspub.33945-ref7">7</xref>]。</p><sec id="s5_1"><title>3.1. 疼痛</title><p>疼痛通常是双侧的，发生于黏膜深处，几乎持续一整天，较少影响睡眠，无加重不恶化，进食时疼痛可以减轻 [<xref ref-type="bibr" rid="hanspub.33945-ref8">8</xref>]。</p></sec><sec id="s5_2"><title>3.2. 感觉异常</title><p>患者主诉口腔干燥，但研究发现原发性BMS患者的唾液流量与健康组差异无统计学意义 [<xref ref-type="bibr" rid="hanspub.33945-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.33945-ref10">10</xref>]。由于感觉的异常，原发性BMS患者描述的口腔干燥大多数与唾液腺的萎缩无关，并非真正的干燥综合征 [<xref ref-type="bibr" rid="hanspub.33945-ref11">11</xref>]。麻、糙、木的症状主诉亦无体征或仪器检测后的支持。</p></sec></sec><sec id="s6"><title>4. BMS的发病原因</title><sec id="s6_1"><title>4.1. 局部因素</title><sec id="s6_1_1"><title>4.1.1. 口腔卫生与健康存在问题</title><p>口腔卫生维护不到位形成的结石堆积以及牙体、牙列问题的存在形成了局部刺激因素。</p></sec><sec id="s6_1_2"><title>4.1.2. 口腔微生物感染</title><p>有研究发现BMS患者口腔黏膜幽门螺旋杆菌检出率较高 [<xref ref-type="bibr" rid="hanspub.33945-ref12">12</xref>]。</p></sec><sec id="s6_1_3"><title>4.1.3. 过敏反应</title><p>有学者 [<xref ref-type="bibr" rid="hanspub.33945-ref1">1</xref>] 认为接触性过敏可能与BMS的发生有关，斑贴试验有阳性比例和去除过敏原效果。</p></sec></sec><sec id="s6_2"><title>4.2. 系统因素</title><sec id="s6_2_1"><title>4.2.1. 内分泌因素</title><p>雌激素水平下降：但围绝经期女性雌激素替代治疗的效果仍存有争议 [<xref ref-type="bibr" rid="hanspub.33945-ref13">13</xref>]。Forabosco等 [<xref ref-type="bibr" rid="hanspub.33945-ref14">14</xref>] 试验结果显示，接受雌二醇补充治疗的27例女性BMS患者中15例疼痛减轻，接受雌三醇补充治疗的22例女性BMS患者中有12例疼痛减轻，而Tarkkila等 [<xref ref-type="bibr" rid="hanspub.33945-ref15">15</xref>] 基于3173名女性调查问卷结果显示，激素替代疗法并不能缓解口干及黏膜烧灼感。以及内分泌如甲状腺的因素 [<xref ref-type="bibr" rid="hanspub.33945-ref1">1</xref>]。</p></sec><sec id="s6_2_2"><title>4.2.2. 糖尿病</title><p>Collin等 [<xref ref-type="bibr" rid="hanspub.33945-ref16">16</xref>] 和Eltas等 [<xref ref-type="bibr" rid="hanspub.33945-ref17">17</xref>] 研究显示，与健康受试者相比，糖尿病患者BMS的患病率显著增加，P值分别&lt;0.01和&lt;0.05。有学者认为糖尿病患者出现口腔烧灼感可能与血管神经病变有关 [<xref ref-type="bibr" rid="hanspub.33945-ref18">18</xref>]。</p></sec><sec id="s6_2_3"><title>4.2.3. 胃肠道疾病</title><p>有学者研究提示胃肠道疾病可能与BMS的发生有关。Lamey等 [<xref ref-type="bibr" rid="hanspub.33945-ref19">19</xref>] 通过多因素回归分析发现，胃炎是BMS患者的一个特征。</p></sec><sec id="s6_2_4"><title>4.2.4. 微量元素</title><p>Lin等 [<xref ref-type="bibr" rid="hanspub.33945-ref20">20</xref>] 比较分析了399例BMS患者与399例健康对照组血清的血红蛋白、铁、维生素B12、叶酸、血同型半胱氨酸浓度水平以及胃壁细胞抗体水平，发现部分BMS患者的血红蛋白(22.3%)、铁(20.3%)和维生素B12 (2.5%)明显缺乏，血液同型半胱氨酸水平(22.3%)异常升高，血清胃壁细胞抗体(13.3%)阳性，然而两组间叶酸水平差异无统计学意义。</p></sec></sec><sec id="s6_3"><title>4.3. 精神神经因素</title><p>作者团队何虹教授认为社会心理因素在BMS中是身体或社会家庭环境中受到不确定信号的刺激。BMS患者常容易有可能伴有抑郁、焦虑等精神心理情况。与Sikorad报道BMS患者常伴随抑郁、焦虑等精神心理问题 [<xref ref-type="bibr" rid="hanspub.33945-ref21">21</xref>] 相吻合。</p><p>Schiavone等 [<xref ref-type="bibr" rid="hanspub.33945-ref22">22</xref>] 通过回归分析发现BMS患者疼痛受到抑郁影响，抑郁受到焦虑影响，并认为焦虑可导致BMS患者出现抑郁，而抑郁可导致疼痛。苏莎等 [<xref ref-type="bibr" rid="hanspub.33945-ref23">23</xref>] 病例对照研究显示，焦虑和抑郁症状的比值比(odds ratio，OR)分别为8.12和2.57，表明焦虑及抑郁是BMS的主要危险因素。Davies [<xref ref-type="bibr" rid="hanspub.33945-ref24">24</xref>] 研究发现，BMS患者的一些特殊症状如味觉异常、金属味、感觉异常也与焦虑抑郁有关。</p><p>还有相吻合和支持作者团队前述句子的是Bogetto等 [<xref ref-type="bibr" rid="hanspub.33945-ref25">25</xref>]，对102例BMS患者分析发现各种社会压力、生活不良事件的刺激是BMS的重要诱因，大多数患者口腔症状的出现早于精神疾病的确诊。而精神心理因素是BMS的诱因还是继发症状仍存在争议 [<xref ref-type="bibr" rid="hanspub.33945-ref26">26</xref>]。精神疾病诊断的滞后性，以及某些局部和系统因素导致的BMS患者，在长期无法治愈的疼痛影响下可能导致心理问题，产生挫败、压抑、恐惧等负面心理，继而出现焦虑、抑郁 [<xref ref-type="bibr" rid="hanspub.33945-ref27">27</xref>]，从而误认为焦虑和抑郁仅仅是BMS的继发症状，造成了争议。</p><p>显然，焦虑和抑郁等精神心理疾患既可以是BMS的致病因素(即BMS可以是焦虑抑郁的早期症状表现)；也可以是BMS的继发病症。</p></sec><sec id="s6_4"><title>4.4. 神经系统病变因素</title><sec id="s6_4_1"><title>4.4.1. 周围型</title><p>Eliav等 [<xref ref-type="bibr" rid="hanspub.33945-ref28">28</xref>] 研究发现，与健康组相比，BMS患者对冷、热刺激较敏感，表现出痛阈降低和味觉阈值升高，提示BMS的烧灼痛和味觉异常可能与舌神经、鼓索神经病变有关。舌前2/3黏膜由舌神经及鼓索神经支配 [<xref ref-type="bibr" rid="hanspub.33945-ref29">29</xref>]，而该区域是BMS最常受到影响的区域 [<xref ref-type="bibr" rid="hanspub.33945-ref3">3</xref>]。O’Neill等 [<xref ref-type="bibr" rid="hanspub.33945-ref30">30</xref>] 研究还发现BMS患者中的角膜神经纤维密度和长度也显著降低。</p></sec><sec id="s6_4_2"><title>4.4.2. 中枢型</title><p>Khan等 [<xref ref-type="bibr" rid="hanspub.33945-ref31">31</xref>] 研究显示，与对照组相比BMS患者的海马体灰质体积增多，内侧前额叶皮质的灰质体积减少。脊髓多巴胺D2受体对疼痛的调节主要通过纹状体多巴胺能下行通路传导 [<xref ref-type="bibr" rid="hanspub.33945-ref32">32</xref>]，提示壳核纹状体中多巴胺能系统功能和内源性疼痛抑制功能的减退与BMS的发生相关 [<xref ref-type="bibr" rid="hanspub.33945-ref33">33</xref>]。</p></sec></sec></sec><sec id="s7"><title>5. BMS的定义和诊断</title><p>国际头痛学会定义了BMS的3个特征 [<xref ref-type="bibr" rid="hanspub.33945-ref34">34</xref>]：① 口腔内烧灼感；② 每天发作至少2 h，病程至少3个月；③ 无明显的临床器质性病变。</p><p>Scala等 [<xref ref-type="bibr" rid="hanspub.33945-ref35">35</xref>] 认为BMS的诊断标准需包含以下内容：① 特征性的疼痛，每日双侧口腔黏膜烧灼样疼痛，病程至少4~6个月，有口腔黏膜深处疼痛的经历，较少影响睡眠，无加重不恶化，饮食会缓解；②伴味觉异常、口干、感觉异常及情绪变化；③ 临床及病理检查口腔黏膜无异常，排除有口腔烧灼痛不适表现的黏膜病如创伤性病变、念珠菌病、复发性阿弗他溃疡、扁平苔藓、白斑、红斑、类天疱疮、天疱疮及肿瘤性病变等，即白斑、红斑、萎缩、糜烂、溃疡或其它各种口腔炎表征；④ 虽有黏膜病损，但去除刺激因素治愈病损后仍有持续性烧灼样疼痛。</p><p>然而，另有调查显示80%的BMS患者反复多方就医 [<xref ref-type="bibr" rid="hanspub.33945-ref36">36</xref>]，寻找其可以接受的诊断和原因，从而导致疼痛病史延长，这意味着BMS患者的首诊疼痛病史其实可以不足3~4个月，甚至可以是在疼痛发生即日就诊。因此，在诊断标准里也许应将疼痛病程去除，根据口腔黏膜的疼痛不适等异常感觉以及临床症状与体征明显不协调的特征，即可做出初步诊断。</p></sec><sec id="s8"><title>6. BMS的主要临床分型</title><sec id="s8_1"><title>6.1. 病因分型</title><p>Ranjbar等 [<xref ref-type="bibr" rid="hanspub.33945-ref6">6</xref>] 的回顾性研究发现，大部分BMS患者能找到相关发病原因。依次占比：局部因素(63.5%)，系统因素(22.8%)，再次为心理因素(5.4%)，未知因素(8.4%)。</p><p>Scala等 [<xref ref-type="bibr" rid="hanspub.33945-ref35">35</xref>] 根据病因首次将BMS分为两种临床类型：① 继发性BMS，有可识别的局部和系统病因，但排除其他口腔颌面部疼痛疾病以及表现为口腔黏膜疼痛不适的口腔疾病；② 原发性BMS，无可疑的局部和系统病因，与心理因素和某些未知因素有关。</p><p>作者团队何虹教授根据临床收集认为，社会心理因素在BMS中是身体或社会家庭环境中受到不确定信号的刺激，占主要的发病概率。这个身体或环境的确定或不确定性事件的刺激，可包括排除口腔相关疾病前提后的继发性或原发性或混合性类型。倾向于唯刺激性病因的精神心理生物神经性病因学说。</p></sec><sec id="s8_2"><title>6.2. 疼痛特点分型</title><p>也有学者根据疼痛特点将BMS分为3种类型 [<xref ref-type="bibr" rid="hanspub.33945-ref8">8</xref>]：I型，疼痛呈间歇性，占据约10%的患者，与过敏反应有关；II型，晨起无痛，白天烧灼感逐渐加重，晚上达峰值，约35%的患者属于该型，与系统性疾病有关，如微量元素缺乏和糖尿病；III型，疼痛持续一整天，影响入睡，约55%的患者为此种类型，通常伴心理疾病。</p></sec></sec><sec id="s9"><title>7. BMS的治疗方法</title><p>主要包括宣教治疗 [<xref ref-type="bibr" rid="hanspub.33945-ref1">1</xref>] 、局部与系统治疗 [<xref ref-type="bibr" rid="hanspub.33945-ref1">1</xref>] 、认知行为治疗、药物辅助治疗以及激光治疗。</p><sec id="s9_1"><title>7.1. 认知行为治疗</title><p>心理认知行为疗法(cognitive behavioral therapy，CBT)通过疾病宣教和沟通疏导、认知和效果引导等方法改变患者的思维认知，来减少不良或偏差的认知行为、增加适应性认知行为，从而消除患者不良情绪和认知感受。Komiyama等 [<xref ref-type="bibr" rid="hanspub.33945-ref37">37</xref>] 研究结果显示，经过CBT后BMS患者的疼痛和焦虑得到改善。</p></sec><sec id="s9_2"><title>7.2. 药物辅助治疗</title><sec id="s9_2_1"><title>7.2.1. 受体相关类</title><p>主要为γ-氨基丁酸(γ-aminobutyric acid，GABA)受体的激动剂，比如氯硝西泮、加巴喷丁，以及tprv1受体结合剂辣椒素 [<xref ref-type="bibr" rid="hanspub.33945-ref38">38</xref>]。</p><p>氯硝西泮全身用药能抑制中枢神经系统，发挥抗惊厥、镇静、肌肉松弛和安定的作用，但也会产生嗜睡、疲劳、头晕、幻觉及共济失调等不良反应 [<xref ref-type="bibr" rid="hanspub.33945-ref39">39</xref>] ；局部用药也可有效减少口腔黏膜烧灼感，可造成患者一定程度的困意，但无全身用药的不良反应 [<xref ref-type="bibr" rid="hanspub.33945-ref40">40</xref>]。Cui等 [<xref ref-type="bibr" rid="hanspub.33945-ref41">41</xref>] 筛选了144篇相关文献，最终选取3篇随机对照试验及2篇高质量的病例对照研究纳入分析，结果显示氯硝西泮能减轻BMS患者口腔疼痛，并且从短期(&lt;10周)、长期(&gt;10周)、局部用药和全身用药的角度分析均能证实其治疗的有效性。然而这5篇文献中氯硝西泮的给药剂量并不一致，氯硝西泮剂量从0.25~2.00 mg不等，一些患者的症状可完全消失，部分患者感到烧灼感增强，同时有部分患者因不能忍受药物的不良反应停止了治疗，因此很难形成关于氯硝西泮的剂量与BMS的效应关系。</p><p>关于tprv1受体结合剂，Verhulst等 [<xref ref-type="bibr" rid="hanspub.33945-ref42">42</xref>] 的随机双盲交叉对照试验结果显示，局部使用0.01%和0.025%的辣椒素凝胶短期内均能显著缓解疼痛，不同浓度间差异并无统计学意义。</p></sec><sec id="s9_2_2"><title>7.2.2. 神经保护类</title><p>α-硫辛酸(alpha lipoic acid，ala)是人体内可自然产生的一种具有抗氧化作用的线粒体辅酶，也存在于一些天然食物中，如土豆、西红柿和菠菜，具有神经保护作用。基于ala在治疗糖尿病患者神经病变中的作用，有学者尝试用其治疗BMS [<xref ref-type="bibr" rid="hanspub.33945-ref43">43</xref>]。相对于安慰剂组，前类GABA受体激动剂加巴喷丁600 mg/d治疗2个月效果高达5.7倍，而联合ala 300 mg/d甚至达13.2倍 [<xref ref-type="bibr" rid="hanspub.33945-ref44">44</xref>]。</p></sec></sec><sec id="s9_3"><title>7.3. 激光治疗</title><p>Al-Maweri等 [<xref ref-type="bibr" rid="hanspub.33945-ref45">45</xref>] 系统评价表明，低强度激光治疗能有效减少BMS患者的口腔烧灼痛。Spanemberg等 [<xref ref-type="bibr" rid="hanspub.33945-ref46">46</xref>] 双盲随机对照试验结果也显示低强度激光疗法能显著缓解疼痛、口干及感觉异常。</p></sec></sec><sec id="s10"><title>8. BMS可能的发病机制与诊疗思路</title><p>基于Scala [<xref ref-type="bibr" rid="hanspub.33945-ref34">34</xref>] 和Patton [<xref ref-type="bibr" rid="hanspub.33945-ref47">47</xref>] 等人的原始图基础、结合临床认知和其他文献，作者团队初拟的BMS可能性发病机制与诊疗思路如图1和图2所示。</p><p>图1. 作者团队基于Scala的BMS可能性发病机制</p><p>图2. 作者团队基于Scala和Patton的BMS目前诊疗思路</p></sec><sec id="s11"><title>基金项目</title><p>卫健委省部共建基金(WKJ-ZJ-1623)；卫健委公益性行业专项基金(201502018)；浙江大学医学院教学改革课题(yxyb20172030)；国家重点研发计划合作项目(2016YFC0902702)。</p></sec><sec id="s12"><title>文章引用</title><p>谢尚丰,何 虹,王雪婷,张馨月,汪 颖. 精神神经社会心理等因素在BMS发病机制中的相关进展Recent Advances of Biological Nerve and Social Psychology in the Pathogenesis of BMS[J]. 临床医学进展, 2020, 10(01): 42-50. https://doi.org/10.12677/ACM.2020.101008</p></sec><sec id="s13"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.33945-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">谢尚丰, 李聪聪, 何虹, 等. 灼口综合征生物神经及社会心理性疾病模式的研究进展[J]. 中华口腔医学, 2020, 55(2): 1-6.</mixed-citation></ref><ref id="hanspub.33945-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Jaaskelainen, S.K. (2018) Is Burning Mouth Syndrome a Neuropathic Pain Condition? Pain, 159, 610-613. https://doi.org/10.1097/j.pain.0000000000001090</mixed-citation></ref><ref id="hanspub.33945-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">周瑜, 黄小瑾, 林梅. 从现代医学与中医学角度认识灼口综合征[J]. 中华口腔医学杂志, 2017, 52(10): 645-648.</mixed-citation></ref><ref id="hanspub.33945-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Aggarwal, A. and Panat, S.R. (2012) Burning Mouth Syndrome: A Diagnostic and Therapeutic Dilemma. Journal of Clinical and Experimental Dentistry, 4, 180-185. https://doi.org/10.4317/jced.50764</mixed-citation></ref><ref id="hanspub.33945-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Kohorst, J.J., Bruce, A.J., Torgerson, R.R., Schenck, L.A. and Davis, M.D. (2014) A Population-Based Study of the Incidence of Burning Mouth Syndrome. Mayo Clinic Proceedings, 89, 1545-1552. https://doi.org/10.1016/j.mayocp.2014.05.018</mixed-citation></ref><ref id="hanspub.33945-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ranjbar, Z., Davarmanesh, M., Zahed, M. and Salehi, S. (2017) Evaluating the Etiologies of Burning Mouth Symptom in Patients of Shiraz Dental School from 2007 to 2015. Iranian Red Crescent Medical Journal, 19, e42675. https://doi.org/10.5812/ircmj.42675</mixed-citation></ref><ref id="hanspub.33945-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Gurvits, G.E. and Tan, A. (2013) Burning Mouth Syndrome. World Journal of Gastroenterology, 19, 665-672. https://doi.org/10.3748/wjg.v19.i5.665</mixed-citation></ref><ref id="hanspub.33945-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Salerno, C., Di Stasio, D., Petruzzi, M., Lauritano, D., Gentile, E., Guida, A., Maio, C., Tammaro, M., Serpico, R. and Lucchese, A. (2016) An Overview of Burning Mouth Syndrome. Frontiers in Bioscience, 8, 213-218. https://doi.org/10.2741/e762</mixed-citation></ref><ref id="hanspub.33945-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">De Moura, S.A., De Sousa, J.M., Lima, D.F., Negreiros, A.N., de Vasconcelos Silva, F. and Da Costa, L.J. (2007) Burning Mouth Syndrome (BMS): Sialometric and Sialochemical Analysis and Salivary Protein Profile. Gerodontology, 24, 173-176. https://doi.org/10.1111/j.1741-2358.2007.00158.x</mixed-citation></ref><ref id="hanspub.33945-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Boras, V.V., Savage, N.W., Brailo, V., Lukac, J., Lukac, M. and Alajbeg, I.Z. (2010) Salivary and Serum Levels of Substance P, Neurokinin A and Calcitonin Gene Related Peptide in Burning Mouth Syndrome. Medicina Oral, Patología Oral y Cirugía Bucal, 15, 427-431. https://doi.org/10.4317/medoral.15.e427</mixed-citation></ref><ref id="hanspub.33945-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kolkka-Palomaa, M., Jaaskelainen, S.K., Laine, M.A., Teerijoki-Oksa, T., Sandell, M. and Forssell, H. (2015) Pathophysiology of Primary Burning Mouth Syndrome with Special Focus on Taste Dysfunction: A Review. Oral Diseases, 21, 937-948. https://doi.org/10.1111/odi.12345</mixed-citation></ref><ref id="hanspub.33945-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Gall-Troselj, K., Mravak-Stipetic, M., Jurak, I., Ragland, W.L. and Pavelic, J. (2001) Helicobacter Pylori Colonization of Tongue Mucosa—Increased Incidence in Atrophic Glossitis and Burning Mouth Syndrome (BMS). Journal of Oral Pathology &amp; Medicine, 30, 560-563. https://doi.org/10.1034/j.1600-0714.2001.300909.x</mixed-citation></ref><ref id="hanspub.33945-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Slebioda, Z. and Szponar, E. (2014) Burning Mouth Syndrome—A Common Dental Problem in Perimenopausal Women. Przegla?d Menopauzalny, 13, 198-202. https://doi.org/10.5114/pm.2014.43825</mixed-citation></ref><ref id="hanspub.33945-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Forabosco, A., Criscuolo, M., Coukos, G., Uccelli, E., Weinstein, R., Spinato, S., Botticelli, A. and Volpe, A. (1992) Efficacy of Hormone Replacement Therapy in Postmenopausal Women with Oral Discomfort. Oral Surgery, Oral Medicine, Oral Pathology, 73, 570-574. https://doi.org/10.1016/0030-4220(92)90100-5</mixed-citation></ref><ref id="hanspub.33945-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Tarkkila, L., Linna, M., Tiitinen, A., Lindqvist, C. and Meurman, J.H. (2001) Oral Symptoms at Menopause—The Role of Hormone Replacement Therapy. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 92, 276-280. https://doi.org/10.1067/moe.2001.117452</mixed-citation></ref><ref id="hanspub.33945-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Collin, H.L., Niskanen, L., Uusitupa, M., Toyry, J., Collin, P., Koivisto, A.M., Viinamaki, H. and Meurman, J.H. (2000) Oral Symptoms and Signs in Elderly Patients with Type 2 Diabetes Mellitus. A Focus on Diabetic Neuropathy. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 90, 299-305. https://doi.org/10.1067/moe.2000.107536</mixed-citation></ref><ref id="hanspub.33945-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Eltas, A., Tozoglu, U., Keles, M. and Canakci V. (2012) Assessment of Oral Health in Peritoneal Dialysis Patients with and without Diabetes Mellitus. Peritoneal Dialysis International, 32, 81-85. https://doi.org/10.3747/pdi.2010.00113</mixed-citation></ref><ref id="hanspub.33945-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Borgnakke, W.S., Anderson, P.F., Shannon, C. and Jivanescu, A. (2015) Is There a Relationship between Oral Health and Diabetic Neuropathy? Current Diabetes Reports, 15, 93. https://doi.org/10.1007/s11892-015-0673-7</mixed-citation></ref><ref id="hanspub.33945-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Lamey, P.J., Freeman, R., Eddie, S.A., Pankhurst, C. and Rees, T. (2005) Vulnerability and Presenting Symptoms in Burning Mouth Syndrome. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 99, 48-54. https://doi.org/10.1016/j.tripleo.2004.01.021</mixed-citation></ref><ref id="hanspub.33945-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Lin, H.P., Wang, Y.P., Chen, H.M., Kuo, Y.S., Lang, M.J. and Sun, A. (2013) Significant Association of Hematinic Deficiencies and High Blood Homocysteine Levels with Burning Mouth Syndrome. Journal of the Formosan Medical Association, 112, 319-325. https://doi.org/10.1016/j.jfma.2012.02.022</mixed-citation></ref><ref id="hanspub.33945-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Sikora, M., Verzak, Z., Matijevic, M., Vcev, A., Siber, S., Music, L. and Carek, A. (2018) Anxiety and Depression Scores in Patients with Burning Mouth Syndrome. Psychiatria Danubina, 30, 466-470. https://doi.org/10.24869/psyd.2018.466</mixed-citation></ref><ref id="hanspub.33945-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Schiavone, V., Adamo, D., Ventrella, G., Morlino, M., De Notaris, E.B., Ravel, M.G., Kusmann, F., Piantadosi, M., Pollio, A., Fortuna, G. and Mignogna, M.D. (2012) Anxiety, Depression, and Pain in Burning Mouth Syndrome: First Chicken or Egg? Headache, 52, 1019-1025. https://doi.org/10.1111/j.1526-4610.2012.02171.x</mixed-citation></ref><ref id="hanspub.33945-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">苏莎, 刘宏伟, 黄悦勤, 等. 灼口综合征与焦虑抑郁症状的病例对照研究[J]. 中国心理卫生杂志, 2015(10): 750-754.</mixed-citation></ref><ref id="hanspub.33945-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Davies, S.J., Underhill, H.C., Abdel-Karim, A., Christmas, D.M., Bolea-Alamanac, B.M., Potokar, J., Herrod, J. and Prime, S.S. (2016) Individual Oral Symptoms in Burning Mouth Syndrome May Be Associated Differentially with Depression and Anxiety. Acta Odontologica Scandinavica, 74, 155-160. https://doi.org/10.3109/00016357.2015.1100324</mixed-citation></ref><ref id="hanspub.33945-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Bogetto, F., Maina, G., Ferro, G., Carbone, M. and Gandolfo, S. (1998) Psychiatric Comorbidity in Patients with Burning Mouth Syndrome. Psychosomatic Medicine, 60, 378-385. https://doi.org/10.1097/00006842-199805000-00028</mixed-citation></ref><ref id="hanspub.33945-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">代青芸, 崔鸢, 冯慧, 等. 灼口综合征的病因及发病机制[J]. 国际口腔医学杂志, 2015, 42(1): 54-58.</mixed-citation></ref><ref id="hanspub.33945-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Brailo, V., Firic, M., Vucicevic, B.V., Andabak, R.A., Krstevski, I. and Alajbeg, I. (2016) Impact of Reassurance on Pain Perception in Patients with Primary Burning Mouth Syndrome. Oral Diseases, 22, 512-516. https://doi.org/10.1111/odi.12493</mixed-citation></ref><ref id="hanspub.33945-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Eliav, E., Kamran, B., Schaham, R., Czerninski, R., Gracely, R.H. and Benoliel, R. (2007) Evidence of Chorda Tympani Dysfunction in Patients with Burning Mouth Syndrome. The Journal of the American Dental Association, 138, 628-633. https://doi.org/10.14219/jada.archive.2007.0234</mixed-citation></ref><ref id="hanspub.33945-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">王美青, 何三纲. 口腔解剖生理学[M]. 第7版. 北京: 人民卫生出版社, 2012: 152-154.</mixed-citation></ref><ref id="hanspub.33945-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">O’Neill, F., Marshall, A., Ferdousi, M. and Malik, R.A. (2019) Corneal Confocal Microscopy Detects Small-Fiber Neuropathy in Burning Mouth Syndrome: A Cross-Sectional Study. Journal of Oral &amp; Facial Pain and Headache, 33, 337-341. https://doi.org/10.11607/ofph.2338</mixed-citation></ref><ref id="hanspub.33945-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Khan, S.A., Keaser, M.L., Meiller, T.F. and Seminowicz, D.A. (2014) Altered Structure and Function in the Hippocampus and Medial Prefrontal Cortex in Patients with Burning Mouth Syndrome. Pain, 155, 1472-1480. https://doi.org/10.1016/j.pain.2014.04.022</mixed-citation></ref><ref id="hanspub.33945-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">宋雨田, 杨清湖, 刘霞, 等. 脊髓多巴胺D2受体对疼痛的调控[J]. 延安大学学报(医学科学版), 2015, 13(1): 51-53.</mixed-citation></ref><ref id="hanspub.33945-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Kolkka, M., Forssell, H., Virtanen, A., Puhakka, A., Pesonen, U. and Jaaskelainen, S.K. (2019) Neurophysiology and Genetics of Burning Mouth Syndrome. European Journal of Pain, 23, 1153-1161. https://doi.org/10.1002/ejp.1382</mixed-citation></ref><ref id="hanspub.33945-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd Edition. Cephalalgia: An International Journal of Headache, 38, 1-211. https://doi.org/10.1177/0333102417738202</mixed-citation></ref><ref id="hanspub.33945-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Scala, A., Checchi, L., Montevecchi, M. and Marini, I. (2003) Update on Burning Mouth Syndrome: Overview and Patient Management. Critical Reviews in Oral Biology &amp; Medicine, 14, 275-291. https://doi.org/10.1177/154411130301400405</mixed-citation></ref><ref id="hanspub.33945-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">杨艳杰, 马杰. 灼口综合症心理学研究进展[J]. 北京口腔医学, 2012, 20(5): 293-295.</mixed-citation></ref><ref id="hanspub.33945-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Komiyama, O., Nishimura, H., Makiyama, Y., Iida, T., Obara, R., Shinoda, M., Kobayashi, M., Noma, N., Abe, O., De Laat, A. and Kawara, M. (2013) Group Cognitive-Behavioral Intervention for Patients with Burning Mouth Syndrome. Journal of Oral Science, 55, 17-22. https://doi.org/10.2334/josnusd.55.17</mixed-citation></ref><ref id="hanspub.33945-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">De Moraes, M., Do Amaral Bezerra, B.A., Da Rocha Neto, P.C., De Oliveira Soares, A.C., Pinto, L.P. and De Lisboa Lopes Costa, A. (2012) Randomized Trials for the Treatment of Burning Mouth Syndrome: An Evidence-Based Review of the Literature. Journal of Oral Pathology &amp; Medicine, 41, 281-287. https://doi.org/10.1111/j.1600-0714.2011.01100.x</mixed-citation></ref><ref id="hanspub.33945-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Amos, K., Yeoh, S.C. and Farah, C.S. (2011) Combined Topical and Systemic Clonazepam Therapy for the Management of Burning Mouth Syndrome: A Retrospective Pilot Study. Journal of Orofacial Pain, 25, 125-130.</mixed-citation></ref><ref id="hanspub.33945-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Rodriguez De Rivera Campillo, E., Lopez-Lopez, J. and Chimenos-Kustner, E. (2010) Response to Topical Clonazepam in Patients with Burning Mouth Syndrome: A Clinical Study. Bulletin du Groupe?ment International Pour la Recherche Scientifique en Stomatologie &amp; Odontologie, 49, 19-29.</mixed-citation></ref><ref id="hanspub.33945-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Cui, Y., Xu, H., Chen, F.M., Liu, J.L., Jiang, L., Zhou, Y. and Chen, Q.M. (2016) Efficacy Evaluation of Clonazepam for Symptom Remission in Burning Mouth Syndrome: A Meta-Analysis. Oral Diseases, 22, 503-511. https://doi.org/10.1111/odi.12422</mixed-citation></ref><ref id="hanspub.33945-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Verhulst, M.J.L., Loos, B.G., Gerdes, V.E.A. and Teeuw, W.J. (2019) Evaluating All Potential Oral Complications of Diabetes Mellitus. Frontiers in Endocrinology, 10, 56. https://doi.org/10.3389/fendo.2019.00056</mixed-citation></ref><ref id="hanspub.33945-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Kisely, S., Forbes, M., Sawyer, E., Black, E. and Lalloo, R. (2016) A Systematic Review of Randomized Trials for the Treatment of Burning Mouth Syndrome. Journal of Psychosomatic Research, 86, 39-46. https://doi.org/10.1016/j.jpsychores.2016.05.001</mixed-citation></ref><ref id="hanspub.33945-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Lopez-D’Alessandro, E. and Escovich, L. (2011) Combination of Alpha Lipoic Acid and Gabapentin, Its Efficacy in the Treatment of Burning Mouth Syndrome: A Randomized, Double-Blind, Placebo Controlled Trial. Medicina Oral, Patologia Oral y Cirugia Bucal, 16, e635-e640. https://doi.org/10.4317/medoral.16942</mixed-citation></ref><ref id="hanspub.33945-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Al-Maweri, S.A., Javed, F., Kalakonda, B., Alaizari, N.A., Al-Soneidar, W. and Al-Akwa, A. (2017) Efficacy of Low Level Laser Therapy in the Treatment of Burning Mouth Syndrome: A Systematic Review. Photodiagnosis and Photodynamic Therapy, 17, 188-193. https://doi.org/10.1016/j.pdpdt.2016.11.017</mixed-citation></ref><ref id="hanspub.33945-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Spanemberg, J.C., Segura-Egea, J.J., Rodriguez-De Rivera-Campillo, E., Jane-Salas, E., Salum, F.G. and Lopez-Lopez, J. (2019) Low-Level Laser Therapy in Patients with Burning Mouth Syndrome: A Double-Blind, Randomized, Controlled Clinical Trial. Journal of Clinical and Experimental Dentistry, 11, e162-e169. https://doi.org/10.4317/jced.55517</mixed-citation></ref><ref id="hanspub.33945-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Patton, L.L., Siegel, M.A., Benoliel, R. and De Laat, A. (2007) Management of Burning Mouth Syndrome: Systematic Review and Management Recommendations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 103, S39.e1-S39.e13. https://doi.org/10.1016/j.tripleo.2006.11.009</mixed-citation></ref></ref-list></back></article>